0001415889-24-006594.txt : 20240305
0001415889-24-006594.hdr.sgml : 20240305
20240305161549
ACCESSION NUMBER: 0001415889-24-006594
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240301
FILED AS OF DATE: 20240305
DATE AS OF CHANGE: 20240305
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Jorgensen Nathan D.
CENTRAL INDEX KEY: 0001842523
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39979
FILM NUMBER: 24720599
MAIL ADDRESS:
STREET 1: C/O VOR BIOPHARMA INC.
STREET 2: 100 CAMBRIDGEPARK DRIVE, SUITE 400
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vor Biopharma Inc.
CENTRAL INDEX KEY: 0001817229
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 CAMBRIDGEPARK DRIVE
STREET 2: SUITE 101
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
BUSINESS PHONE: 617-655-6580
MAIL ADDRESS:
STREET 1: 100 CAMBRIDGEPARK DRIVE
STREET 2: SUITE 101
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
4
1
form4-03052024_040329.xml
X0508
4
2024-03-01
0001817229
Vor Biopharma Inc.
VOR
0001842523
Jorgensen Nathan D.
C/O VOR BIOPHARMA INC.
100 CAMBRIDGEPARK DRIVE, SUITE 101
CAMBRIDGE
MA
02140
false
true
false
false
CHIEF FINANCIAL OFFICER
0
Common Stock
2024-03-01
4
F
0
6310
2.27
D
191154
D
Shares were withheld to satisfy the Reporting Person's tax withholding obligations in connection with the settlement of restricted stock units.
/s/ Katie Kazem, Attorney-in-Fact
2024-03-05